ArticleERJ open research2026

Erratum: "Long-term impact of elexacaftor/tezacaftor/ivacaftor on small and large airways in people with cystic fibrosis aged ≥6 years: 24-month real-world evidence from the German Cystic Fibrosis Registry" Stefanie Dillenhöfer, Katharina Schütz, Manuel Burkhart, Helmut Ellemunter, Matthias Kappler, Sarah Sieber, Lutz Naehrlich, Folke Brinkmann and Sivagurunathan Sutharsan on behalf of the German CF Registry of the Mukoviszidose e.V. and participating cystic fibrosis sites.

PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.